Not particularly special: critiquing ‘NPS’ as a category of drugs

References

• Adley, M. (2015). The drugs wheel: A new model for substance awareness. Retrieved from www.thedrugswheel.com
   Google Scholar
• Alexandrescu, L. (2016). Legally high, offically lost: Injecting NPS use and drug abjection in post-communist Romania (PhD thesis, Lancaster University).
   Google Scholar
• Alexandrescu, L. (2017a). NPS and the methadone queue: Spillages of space and time. International Journal of Drug Policy, 40, 50–56. doi: 10.1016/j.drugpo.2016.09.009
   PubMed Web of Science ®Google Scholar
• Alexandrescu, L. (2017b) Spice is not the real problem, it’s the way we look at poverty, Volteface, Retrieved from www.volteface.me
   Google Scholar
• Anderson, D., Beckerleg, S., Hailu, D., & Klein, A. (2007). The Khat controversy: Stimulating the debate on drugs. Oxford: Berg.
   Google Scholar
• Barratt, M., & Aldridge, J. (2016). Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask). International Journal of Drug Policy, 35, 1–6. doi:10.1016/j.drugpo.2016.07.005
   PubMed Web of Science ®Google Scholar
• Barratt, M.J., & Lenton, S. (2013). Drugs and the internet. In A. Ritter, T. King & M. Hamilton (Eds.), Drug use in Australian society. Melbourne: Oxford University Press.
   Google Scholar
• Barratt, M., Seear, K., & Lancaster, K. (2017). A critical examination of the definition of ‘psychoactive effect’ in Australian drug legislation. International Journal of Drug Policy, 40, 16–25. doi: 10.1016/j.drugpo.2016.10.002
   PubMed Web of Science ®Google Scholar
• Bauman, Z. (2000). Liquid Modernity. Cambridge: Policy Press.
   Google Scholar
• Bauman, Z. (2007). Liquid times: Living in an age of uncertainty. Cambridge: Polity Press.
   Google Scholar
• Beck, U. (1992). Risk society: Towards a new modernity. London: Sage.
   Google Scholar
• Birdwell, J., Chapman, J. & Singleton, N. (2011). Taking drugs seriously: A demos and UK drug policy commission report on legal highs. Retrieved from www.ukdpc.org.uk
   Google Scholar
• Blackman, S., & Bradley, R. (2017). From niche to stigma – Headshops to prison; Exploring the rise and fall of synthetic cannabinoid use among young adults. International Journal of Drug Policy, 40, 70–77. doi:10.1016/j.drugpo.2016.10.015
   PubMed Web of Science ®Google Scholar
• Boothroyd, D. (2016). Roundtable: New drugs and the “bigger picture”. In ESRC Seminar Series on new drugs. University of Kent, 6th September, 2016.
   Google Scholar
• Boothroyd, D., & Lewis, S. (2016). Rethinking evidence in online social drug use research. In A. O’Gorman, G. Potter & J. Fountain (Eds.), Evidence in European social drug research and drug policy. Lengerich: Pabst.
   Google Scholar
• Chatwin, C. (2014). New psychoactive substances: New European policy landscapes. In G. Potter, M. Wouters, & J. Fountain (Eds.), Change and continuity: Researching evolving drug landscapes in Europe. Lengerich: Pabst.
   Google Scholar
• Chatwin, C. (2017). Assessing the ‘added value’ of European policy on new psychoactive substances. International Journal of Drug Policy, 40, 111–116. doi: 10.1016/j.drugpo.2016.11.002
   PubMed Web of Science ®Google Scholar
• Chatwin, C., Measham, F., O’brien, K., & Sumnall, H. (2017). New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. International Journal of Drug Policy, 40, 1–5. doi: 10.1016/j.drugpo.2017.01.016
   PubMed Web of Science ®Google Scholar
• Christie, N., & Bruun, K. (1985). Den gode fiende: narkotikapolitikk I Norden (English Summary). Oslo: Universitetsforlaget.
   Google Scholar
• Council of the European Union. (2005). Council decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances. Brussels: Council of the European Union, OJ L127.
   Google Scholar
• Dąbrowska, K., & Bujalski, M. (2014). A liquid phenomenon? Images of new psychoactive substances in Polish print media. In G. Potter, M. Wouters & J. Fountain (Eds.), Change and continuity: Researching evolving drug landscapes in Europe. Lengerich: Pabst.
   Google Scholar
• Daly, M. (2016). Tabloid Scare Stories About Drugs Actually Make People Buy More Drugs, Vice 18th July 2016. Retrieved from https://www.vice.com/en_uk/article/3b4bzk/tabloid-scare-stories-about-drugs-actually-make-people-buy-more-drugs-narcomania
   Google Scholar
• Decorte, T., & Potter, G. (2015). The globalisation of cannabis cultivation: A growing challenge. International Journal of Drug Policy, 26, 221–225. doi: 10.1016/j.drugpo.2014.12.011
   PubMed Web of Science ®Google Scholar
• Decorte, T., Potter, G. & Bouchard, M. (Eds.) (2011). World Wide Weed: Global trends in cannabis cultivation and control. Aldershot: Ashgate.
   Google Scholar
• Dimoldenberg, A. (2016). Turns out Poppers aren’t banned in the UK, even the politicians thought they were, Vice’, 16th March 2016.
   Google Scholar
• EMCDDA. (2013). European Drug Report 2013: Trends and developments. Retrieved from: www.emcdda.europa.eu
   Google Scholar
• EMCDDA. (2017). European Drug Report 2017: Trends and developments. Retrieved from: www.emcdda.europa.eu
   Google Scholar
• European Commission. (2011). Towards a stronger European drug policy. Brussels: European Commission, COM 689 final.
   Google Scholar
• European Council. (1997). Joint Action of 16 June 1997 adopted by the council on the basis of article K.2 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs 97/39/JHA.
   Google Scholar
• Evans-Brown, M., McVeigh, J., Perkins, C., & Bellis, M.A. (2012). Human enhancement drugs: The emerging challenges to public health. Liverpool: North West Public Health Observatory.
   Google Scholar
• Farand, C. (2017). Laughing gas ban: Judge rules ‘hippy crack’ still legal despite law which bans psychoactive substances. The Independent, 31st August, 2017.
   Google Scholar
• Forsyth, A.J. (2012). Virtually a drug scare: Mephedrone and the impact of the Internet on drug news transmission. International Journal of Drug Policy, 23, 198–209. doi:10.1016/j.drugpo.2011.12.003
   PubMed Web of Science ®Google Scholar
• Giese, C., Igoe, D., Gibbons, Z., Hurley, C., Stokes, S., McNamara, S., & Fitzgerald, M. (2015). Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland. Eurosurveillance, 20, pii=30036. doi:10.2807/1560-7917.ES.2015.20.40.30036
   Web of Science ®Google Scholar
• Griffiths, P., Sedefov, R., Gallegos, A., & Lopez, D. (2010). How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case study. Addiction, 105, 951–953. doi:10.1111/j.1360-0443.2009.02874.x
   PubMed Web of Science ®Google Scholar
• Gromyko, D. (2016). New psychoactive substances. In D. Lader (Ed.), Drug misuse: Findings from the 2015/16 Crime Survey for England and Wales, 2nd ed. London: Home Office/Office for National Statistics.
   Google Scholar
• Harry, J. (2017). The Psychoactive Substances Act is mostly helping London police arrest NOS sellers, Vice, 23rd January 2017.
   Google Scholar
• Horsley, M. (2017). Forget ‘Moral Panics’ Journal of Theoretical & Philosophical Criminology, 9, 84–98. Retrieved from http://www.jtpcrim.org/AUGUST2017/Horsley.pdf
   Google Scholar
• Hughes, B., & Winstock, A.R. (2011). Controlling new drugs under marketing regulations. Addiction, 107, 1894–1899. doi:10.1111/j.1360-0443.2011.03620.x
   Web of Science ®Google Scholar
• INCB. (2011) Report of the International Narcotics Control Board for 2011. Retrieved from www.unodc.org
   Google Scholar
• Karlsson, P. (2010). Alternatives to the deficit model of adolescent drug use. In Decorte, T. & Fountain, J. (Eds), Pleasure, pain and profit: European perspectives on drugs. Lengerich: Pabst.
   Google Scholar
• Lader, D. (Ed.) (2016). Drug misuse: Findings from the 2015/16 crime survey for England and Wales. 2nd ed. London: Home Office/Office for National Statistics.
   Google Scholar
• Martins, D., Barratt, M.J., Pires, C.V., Carvalho, H., Vilamala, M.V., Espinosa, I.F., & Valente, H. (2017). The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Boom Festival. Human Psychopharmacology: Clinical and Experimental, 32, e2608. doi:10.1002/hup.2608
   Web of Science ®Google Scholar
• Measham, F. (2013). Social issues in the use of novel psychoactive substances. In P.I. Dargan & D.M. Woods (Eds.), Novel psychoactive substances: Classification, pharmacology and toxicology. London: Academic Press.
   Google Scholar
• Measham, F., Moore, K., Newcombe, R., & Welch, Z. (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10, 14–21. doi:10.5042/daat.2010.0123
   Google Scholar
• Measham, F. & Newcombe, R. (2016). What’s so new about new psychoactive substances? Definitions, prevalence, motivations, user groups and a proposed new taxonomy. In T. Kolind, B. Thom and G. Hunt (Eds.), The SAGE handbook of drug & alcohol studies (Vol. 1, pp. 576–596). London: Sage.
   Google Scholar
• Newcombe, R. (2015). NPS taxonomy: A framework for classifying new psychoactive substances. Conference paper presented at the ESRC seminar series on new drugs: supply and demand – drug markets in transition Durham University, 26th March, 2015. Retrieved from www.backdoorbroadcasting.net
   Google Scholar
• O’Brien, K., Chatwin, C., Jenkins, C., & Measham, F. (2015). New psychoactive substances and British drug policy: A view from the cyber-psychonauts. Drugs: Education, Prevention and Policy, 22, 1–7. doi: 10.3109/09687637.2014.989959
   Web of Science ®Google Scholar
• Potter, G. (2014). Change and continuity in the European drug landscape: An introduction, In G. Potter, M. Wouters & J. Fountain (Eds.), Change and continuity: Researching evolving drug landscapes in Europe. Lengerich: Pabst.
   Google Scholar
• Quintana, P., Ventura, M., Grifell, M., Palma, A., Galindo, L., Fornis, I., … Torrens, M. (2017). The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. International Journal of Drug Policy, 40, 78–83. doi: 10.1016/j.drugpo.2016.10.006
   PubMed Web of Science ®Google Scholar
• Ralphs, R., Williams, L., Askew, R., & Norton, A. (2017). Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison. International Journal of Drug Policy, 40, 57–69. doi:10.1016/j.drugpo.2016.10.003
   PubMed Web of Science ®Google Scholar
• Reuter, P. (2011). Options for regulating new psychoactive drugs: A review of recent experiences. London: UK Drug Policy Commission.
   Google Scholar
• Reuter, P., & Pardo, B. (2017). New psychoactive substances: Are there any good options for regulating new psychoactive substances? International Journal of Drug Policy, 40, 117–122. doi:10.1016/j.drugpo.2016.10.020
   PubMed Web of Science ®Google Scholar
• RT News. (2014). 25 killed, over 700 hospitalised: Cheap ‘Spice’ designer drug causes severe poisoning across Russia. Retrieved from www.rt.com/news
   Google Scholar
• Ruz, C. (2015). How dangerous is laughing gas? BBC News Magazine, 31st July 2015.
   Google Scholar
• Sare, J. (2011). How the media helped ban mephedrone. British Medical Journal, 342, d1138. doi: 10.1136/bmj.d1138
   PubMed Web of Science ®Google Scholar
• Seddon, T. (2014). Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS). International Journal of Drug Policy, 25, 1019–1024. doi:10.1016/j.drugpo.2014.03.009
   PubMed Web of Science ®Google Scholar
• Shulgin, A., & Shulgin, A. (1990). PiHKAL: A chemical love story. Lafayette: Transform Press.
   Google Scholar
• Shulgin, A., & Shulgin, A. (1997). TiHKAL: The continuation. Lafayette: Transform Press.
   Google Scholar
• Stevens, A., & Measham, F. (2014). The ‘drug policy ratchet’: Why do sanctions for new psychoactive substances typically only go up? Addiction, 109, 1226–1232. doi: 10.111/add.12406
   PubMed Web of Science ®Google Scholar
• Stevens, A., Fortson, R., Measham, F., & Sumnall, H. (2015). Legally flawed, scientifically problematic, potentially harmful: The UK Psychoactive Substance Bill. International Journal of Drug Policy, 26, 1167–1170. doi:10.1016/j.drugpo.2015.10.005
   PubMed Web of Science ®Google Scholar
• Toffler, A. (1970). Future shock. New York: Random House.
   Google Scholar
• UNODC. (2013). The challenge of new psychoactive substances. Global Smart Programme.
   Google Scholar
• UNODC. (2016). Word Drug Report 2016. Vienna: UNODC.
   Google Scholar
• van Amsterdam, J., & van den Brink, W. (2015). The misuse of prescription opioids: A threat for Europe? Current Drug Abuse Reviews, 8, 3–14. doi:10.2174/187447370801150611184218
   PubMedGoogle Scholar
• van Amsterdam, J., Nutt, D., & van den Brink, W. (2013). Generic legislation of new psychoactive drugs. Journal of Psychopharmacology, 27, 317–324. doi:10.1177/0269881112474525
   PubMed Web of Science ®Google Scholar
• Wilkins, C., & Rychert, M. (2017). Recent developments with the New Zealand regulated market approach to ‘low-risk’ psychoactive products. Addiction, 112, 34–36. doi: 10.1111/add.13495
   PubMed Web of Science ®Google Scholar
• Wilson, C. (2016). Addiction to prescription drugs is UK “public health disaster. New Scientist, Daily News 24th October 2016.
   Google Scholar
• Winstock, A., & Ramsey, J. (2010). Legal highs and the challenges for policy makers. Addiction, 105, 1685–1687. doi:10.1111/j.1360-0443.2010.02934.x
   PubMed Web of Science ®Google Scholar
• Young, J. (2007). The vertigo of late modernity. London: Sage.
   Google Scholar
• Zinberg, N. (1984). Drug, set and setting. Yale: Yale University Press.
   Google Scholar